Trailing Dividend / Share
$0.00
Amicus Therapeutics, Inc. (FOLD) Dividend History
Income profile from 2005 to 2024 with payout safety and yield-on-cost trend
Dividend Yield
N/A
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
3-Second Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
Dividend Scorecard
Yield & Income
Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score5/9
Growth
Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return51.4%
5Y Total Return21.9%
Estimated $10K growth (return + dividends):
5Y ago$12,18810Y ago$23,32820Y ago$9,958
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
Dividend History
No dividend payment history available
This company has not paid dividends during the available data period.
Dividend Analysis
Payout Safety
Amicus Therapeutics, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 5/9 — moderate financial health.
Growth Track Record
FOLD does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, FOLD returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is 21.9%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $23,328 today.
Annual Dividend History
20 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | — | 0 | $-0.18 | — | — | — |
| 2023 | $0.00 | — | 0 | $-0.51 | — | — | — |
| 2022 | $0.00 | — | 0 | $-0.82 | — | — | — |
| 2021 | $0.00 | — | 0 | $-0.92 | — | — | — |
| 2020 | $0.00 | — | 0 | $-1.07 | — | — | — |
| 2019 | $0.00 | — | 0 | $-1.48 | — | — | — |
| 2018 | $0.00 | — | 0 | $-1.88 | — | — | — |
| 2017 | $0.00 | — | 0 | $-1.85 | — | — | — |
| 2016 | $0.00 | — | 0 | $-1.49 | — | — | — |
| 2015 | $0.00 | — | 0 | $-1.20 | — | — | — |
See FOLD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FOLD Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare FOLD vs AGIO
See how FOLD stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How much dividend does FOLD pay per share?
Amicus Therapeutics, Inc. (FOLD) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is FOLD's next ex-dividend date?
FOLD's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. FOLD typically pays dividends quarterly.
Is FOLD's dividend safe?
FOLD's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has FOLD increased its dividend?
FOLD has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does FOLD pay dividends?
Amicus Therapeutics, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 19+ years from 2005 to 2024.
How much would $10,000 invested in FOLD grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in FOLD five years ago would be worth approximately $12,188 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is FOLD's yield on cost for long-term holders?
FOLD's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.